Human serum derived from off the clot human serum and processed through four sequential activated charcoal treatments to reduce endogenous hormones, steroids, lipids, and other low molecular weight components. Lipids and other native serum constituents remain present within the matrix.
Collection, processing, and release are performed under defined manufacturing procedures with established specifications to support reproducibility and batch consistency.
Supplied in specified quantities to support research and further manufacturing applications. Custom processing parameters and volumes available upon request.
For research use or further manufacturing of non injectable products only.